{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T04:45:30Z","timestamp":1775191530514,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22ek0109609h0001"],"award-info":[{"award-number":["22ek0109609h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23ek0109609h0002"],"award-info":[{"award-number":["23ek0109609h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24ek0109609h0003"],"award-info":[{"award-number":["24ek0109609h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22KJ1211"],"award-info":[{"award-number":["22KJ1211"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12185-025-04040-x","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T05:47:22Z","timestamp":1753422442000},"page":"864-876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Expression profiling of Epstein\u2013Barr virus-derived microRNA in systemic chronic active EBV disease"],"prefix":"10.1007","volume":"122","author":[{"given":"Mayumi","family":"Yoshimori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwako","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runa","family":"Shimomaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morito","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryusuke","family":"Nabeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8275-5372","authenticated-orcid":false,"given":"Ayako","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"issue":"7","key":"4040_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720\u201348.","journal-title":"Leukemia"},{"issue":"5","key":"4040_CR2","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1086\/423285","volume":"190","author":"N Sugaya","year":"2004","unstructured":"Sugaya N, Kimura H, Hara S, Hoshino Y, Kojima S, Morishima T, et al. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection. J Infect Dis. 2004;190(5):985\u20138.","journal-title":"J Infect Dis"},{"issue":"6","key":"4040_CR3","first-page":"583","volume":"58","author":"H Shibayama","year":"2017","unstructured":"Shibayama H, Imadome KI, Onozawa E, Tsuzura A, Miura O, Koyama T, et al. Virus-specific cytotoxic T cells in chronic active Epstein-Barr virus infection. Rinsho Ketsueki. 2017;58(6):583\u20138.","journal-title":"Rinsho Ketsueki"},{"issue":"5","key":"4040_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s10875-017-0396-4","volume":"37","author":"Y Sekinaka","year":"2017","unstructured":"Sekinaka Y, Mitsuiki N, Imai K, Yabe M, Yabe H, Mitsui-Sekinaka K, et al. Common variable immunodeficiency caused by FANC mutations. J Clin Immunol. 2017;37(5):434\u201344.","journal-title":"J Clin Immunol"},{"issue":"4","key":"4040_CR5","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1182\/blood-2003-06-2171","volume":"103","author":"H Katano","year":"2004","unstructured":"Katano H, Ali MA, Patera AC, Catalfamo M, Jaffe ES, Kimura H, et al. Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood. 2004;103(4):1244\u201352.","journal-title":"Blood"},{"key":"4040_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fped.2019.00015","volume":"7","author":"K Tanita","year":"2019","unstructured":"Tanita K, Hoshino A, Imadome KI, Kamiya T, Inoue K, Okano T, et al. Epstein-Barr virus-associated \u03b3\u03b4 T-cell lymphoproliferative disorder associated with hypomorphic IL2RG mutation. Front Pediatr. 2019;7:15.","journal-title":"Front Pediatr"},{"issue":"12","key":"4040_CR7","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1084\/jem.20190678","volume":"216","author":"R Rodriguez","year":"2019","unstructured":"Rodriguez R, Fournier B, Cordeiro DJ, Winter S, Izawa K, Martin E, et al. Concomitant PIK3CD and TNFRSF9 deficiencies cause chronic active Epstein-Barr virus infection of T cells. J Exp Med. 2019;216(12):2800\u201318.","journal-title":"J Exp Med"},{"issue":"2","key":"4040_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215\u201333.","journal-title":"Cell"},{"key":"4040_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051723","author":"Z Ali Syeda","year":"2020","unstructured":"Ali Syeda Z, Langden SSS, Munkhzul C, Lee M, Song SJ. Regulatory mechanism of microRNA expression in cancer. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21051723.","journal-title":"Int J Mol Sci"},{"key":"4040_CR10","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.3389\/fmicb.2017.01318","volume":"8","author":"H Kim","year":"2017","unstructured":"Kim H, Iizasa H, Kanehiro Y, Fekadu S, Yoshiyama H. Herpesviral microRNAs in cellular metabolism and immune responses. Front Microbiol. 2017;8:1318.","journal-title":"Front Microbiol"},{"key":"4040_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.omtn.2019.07.002","volume":"17","author":"M Wang","year":"2019","unstructured":"Wang M, Gu B, Chen X, Wang Y, Li P, Wang K. The function and therapeutic potential of Epstein-Barr virus-encoded microRNAs in cancer. Mol Ther Nucleic Acids. 2019;17:657\u201368.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"4040_CR12","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.virol.2011.01.028","volume":"412","author":"AR Marquitz","year":"2011","unstructured":"Marquitz AR, Mathur A, Nam CS, Raab-Traub N. The Epstein-Barr virus BART microRNAs target the pro-apoptotic protein Bim. Virology. 2011;412(2):392\u2013400.","journal-title":"Virology"},{"issue":"10","key":"4040_CR13","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/onc.2013.71","volume":"33","author":"DT Vereide","year":"2014","unstructured":"Vereide DT, Seto E, Chiu YF, Hayes M, Tagawa T, Grundhoff A, et al. Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene. 2014;33(10):1258\u201364.","journal-title":"Oncogene"},{"issue":"23","key":"4040_CR14","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1182\/blood-2017-07-794529","volume":"131","author":"H Higuchi","year":"2018","unstructured":"Higuchi H, Yamakawa N, Imadome KI, Yahata T, Kotaki R, Ogata J, et al. Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma. Blood. 2018;131(23):2552\u201367.","journal-title":"Blood"},{"issue":"5","key":"4040_CR15","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/infdis\/jit222","volume":"208","author":"Y Kawano","year":"2013","unstructured":"Kawano Y, Iwata S, Kawada J, Gotoh K, Suzuki M, Torii Y, et al. Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection. J Infect Dis. 2013;208(5):771\u20139.","journal-title":"J Infect Dis"},{"issue":"5","key":"4040_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1046\/j.1365-2141.2003.04359.x","volume":"121","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Nagata H, Ikeuchi T, Mukai H, Oyoshi MK, Demachi A, et al. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T\/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions. Br J Haematol. 2003;121(5):805\u201314.","journal-title":"Br J Haematol"},{"issue":"3","key":"4040_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, et al. EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119(3):673\u201386.","journal-title":"Blood"},{"issue":"13","key":"4040_CR18","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1182\/bloodadvances.2020001451","volume":"4","author":"I Yonese","year":"2020","unstructured":"Yonese I, Sakashita C, Imadome KI, Kobayashi T, Yamamoto M, Sawada A, et al. Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. Blood Adv. 2020;4(13):2918\u201326.","journal-title":"Blood Adv"},{"issue":"6","key":"4040_CR19","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ajh.26544","volume":"97","author":"M Yamamoto","year":"2022","unstructured":"Yamamoto M, Sato M, Onishi Y, Sasahara Y, Sano H, Masuko M, et al. Registry data analysis of hematopoietic stem cell transplantation on systemic chronic active Epstein-Barr virus infection patients in Japan. Am J Hematol. 2022;97(6):780\u201390.","journal-title":"Am J Hematol"},{"issue":"7","key":"4040_CR20","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1182\/bloodadvances.2020002417","volume":"5","author":"M Yoshimori","year":"2021","unstructured":"Yoshimori M, Shibayama H, Imadome KI, Kawano F, Ohashi A, Nishio M, et al. Antineoplastic and anti-inflammatory effects of bortezomib on systemic chronic active EBV infection. Blood Adv. 2021;5(7):1805\u201315.","journal-title":"Blood Adv"},{"issue":"1","key":"4040_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1128\/JCM.37.1.132-136.1999","volume":"37","author":"H Kimura","year":"1999","unstructured":"Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol. 1999;37(1):132\u20136.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"4040_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/0092-8674(86)90803-2","volume":"47","author":"N Raab-Traub","year":"1986","unstructured":"Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell. 1986;47(6):883\u20139.","journal-title":"Cell"},{"issue":"1","key":"4040_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jviromet.2007.08.012","volume":"147","author":"N Kubota","year":"2008","unstructured":"Kubota N, Wada K, Ito Y, Shimoyama Y, Nakamura S, Nishiyama Y, et al. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection. J Virol Methods. 2008;147(1):26\u201336.","journal-title":"J Virol Methods"},{"issue":"8","key":"4040_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042193","volume":"7","author":"N Motsch","year":"2012","unstructured":"Motsch N, Alles J, Imig J, Zhu J, Barth S, Reineke T, et al. Microrna profiling of Epstein-Barr virus-associated NK\/T-cell lymphomas by deep sequencing. PLoS ONE. 2012;7(8): e42193.","journal-title":"PLoS ONE"},{"issue":"3","key":"4040_CR25","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41564-018-0334-0","volume":"4","author":"Y Okuno","year":"2019","unstructured":"Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, et al. Defective Epstein-Barr virus in chronic active infection and haematological malignancy. Nat Microbiol. 2019;4(3):404\u201313.","journal-title":"Nat Microbiol"},{"issue":"12","key":"4040_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00394-22","volume":"96","author":"W Wongwiwat","year":"2022","unstructured":"Wongwiwat W, Fournier B, Bassano I, Bayoumy A, Elgueta Karstegl C, Styles C, et al. Epstein-Barr virus genome deletions in Epstein-Barr virus-positive T\/NK cell lymphoproliferative diseases. J Virol. 2022;96(12): e0039422.","journal-title":"J Virol"},{"issue":"9","key":"4040_CR27","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1261\/rna.1560209","volume":"15","author":"G Sun","year":"2009","unstructured":"Sun G, Yan J, Noltner K, Feng J, Li H, Sarkis DA, et al. SNPs in human miRNA genes affect biogenesis and function. RNA. 2009;15(9):1640\u201351.","journal-title":"RNA"},{"issue":"1","key":"4040_CR28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/humu.21641","volume":"33","author":"J Gong","year":"2012","unstructured":"Gong J, Tong Y, Zhang HM, Wang K, Hu T, Shan G, et al. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat. 2012;33(1):254\u201363.","journal-title":"Hum Mutat"},{"issue":"15","key":"4040_CR29","doi-asserted-by":"publisher","first-page":"8086","DOI":"10.1128\/JVI.00234-12","volume":"86","author":"X Yu","year":"2012","unstructured":"Yu X, McCarthy PJ, Wang Z, Gorlen DA, Mertz JE. Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus. J Virol. 2012;86(15):8086\u201396.","journal-title":"J Virol"},{"issue":"15","key":"4040_CR30","doi-asserted-by":"publisher","first-page":"7976","DOI":"10.1128\/JVI.00770-12","volume":"86","author":"SD Ma","year":"2012","unstructured":"Ma SD, Yu X, Mertz JE, Gumperz JE, Reinheim E, Zhou Y, et al. An Epstein-Barr virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model. J Virol. 2012;86(15):7976\u201387.","journal-title":"J Virol"},{"issue":"2","key":"4040_CR31","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.celrep.2013.09.012","volume":"5","author":"MH Tsai","year":"2013","unstructured":"Tsai MH, Raykova A, Klinke O, Bernhardt K, G\u00e4rtner K, Leung CS, et al. Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas. Cell Rep. 2013;5(2):458\u201370.","journal-title":"Cell Rep"},{"issue":"8","key":"4040_CR32","first-page":"3201","volume":"32","author":"JY Chan","year":"2012","unstructured":"Chan JY, Gao W, Ho WK, Wei WI, Wong TS. Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma. Anticancer Res. 2012;32(8):3201\u201310.","journal-title":"Anticancer Res"},{"key":"4040_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041168","author":"M Navari","year":"2018","unstructured":"Navari M, Etebari M, Ibrahimi M, Leoncini L, Piccaluga PP. Pathobiologic roles of Epstein-Barr virus-encoded microRNAs in human lymphomas. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19041168.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4040_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/CEJ.0000000000000221","volume":"26","author":"Y Wang","year":"2017","unstructured":"Wang Y, Guo Z, Shu Y, Zhou H, Wang H, Zhang W. BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma. Eur J Cancer Prev. 2017;26(2):144\u201350.","journal-title":"Eur J Cancer Prev"},{"issue":"4","key":"4040_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/25785826.2018.1556030","volume":"41","author":"A Arai","year":"2018","unstructured":"Arai A. Chronic active Epstein-Barr virus infection: a bi-faceted disease with inflammatory and neoplastic elements. Immunol Med. 2018;41(4):162\u20139.","journal-title":"Immunol Med"},{"key":"4040_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13205097","author":"M Yoshimori","year":"2021","unstructured":"Yoshimori M, Nishio M, Ohashi A, Tateishi M, Mimura A, Wada N, et al. Interferon-\u03b3 produced by EBV-positive neoplastic NK-cells induces differentiation into macrophages and procoagulant activity of monocytes, which leads to HLH. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13205097.","journal-title":"Cancers (Basel)"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04040-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-04040-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04040-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T08:23:42Z","timestamp":1763713422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-04040-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4040"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-04040-x","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"28 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RN is an employee of Ono Pharmaceutical Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}